Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Return on Capital Employed (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Return on Capital Employed for 3 consecutive years, with 0.66% as the latest value for Q3 2025.

  • Quarterly Return on Capital Employed fell 8.0% to 0.66% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.66% through Sep 2025, down 8.0% year-over-year, with the annual reading at 0.3% for FY2011, N/A changed from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.66% at Lexicon Pharmaceuticals, roughly flat from 0.66% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.38% in Q2 2024, with the low at 0.66% in Q3 2025.